Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07405294
Eligibility Criteria:
Inclusion Criteria:
* Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
* Gestational age \<70 days (based on best obstetrical dating)
* English or Spanish speaking
Exclusion Criteria:
* Received mifepristone and misoprostol for early pregnancy loss
* Patient determined to have contraindication to medication abortion
* Opted for procedural management instead of medication abortion
* Decided to continue with the pregnancy
* Presenting for a second medication abortion at CUIMC during the study period
* Non-English or Spanish speaking
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT07405294
Study Brief:
Protocol Section:
NCT07405294